Emerging platinum(iv) prodrugs to combat cisplatin resistance: from isolated cancer cells to tumor microenvironment
Author:
Affiliation:
1. Department of Chemistry
2. City University of Hong Kong
3. P. R. China
4. School of Pharmaceutical Sciences
5. Health Science Center
6. City University of Hong Kong Shenzhen Research Institute
7. Shenzhen
Abstract
In this Perspective, we discuss various types of novel cisplatin-based Pt(iv) complexes including those targeting the tumor microenvironment.
Funder
Shenzhen Science and Technology Innovation Commission
City University of Hong Kong
Publisher
Royal Society of Chemistry (RSC)
Subject
Inorganic Chemistry
Link
http://pubs.rsc.org/en/content/articlepdf/2019/DT/C8DT03923B
Reference73 articles.
1. Update of the Preclinical Situation of Anticancer Platinum Complexes: Novel Design Strategies and Innovative Analytical Approaches
2. Cellular processing of platinum anticancer drugs
3. The state-of-play and future of platinum drugs
4. Cisplatin in cancer therapy: Molecular mechanisms of action
5. The resurgence of platinum-based cancer chemotherapy
Cited by 120 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. A novel anti-angiogenesis peptide in combination with cisplatin self-assembling into tube-like nanomedicine for oral treatment of gastric cancer;Chemical Engineering Journal;2024-09
2. Anticancer Effect of PtIIPHENSS, PtII5MESS, PtII56MESS and Their Platinum(IV)-Dihydroxy Derivatives against Triple-Negative Breast Cancer and Cisplatin-Resistant Colorectal Cancer;Cancers;2024-07-15
3. Deciphering the Molecular Mechanisms behind Drug Resistance in Ovarian Cancer to Unlock Efficient Treatment Options;Cells;2024-05-04
4. Selective Targeting of Regulated Rhabdomyosarcoma Cells by Trinuclear Ruthenium(II)–Arene Complexes;Journal of Medicinal Chemistry;2024-04-03
5. Platinum(IV) and platinum(II) anticancer complexes with biologically active releasable ligands;Coordination Chemistry Reviews;2024-02
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3